-
Insulin lispro, sold
under the
brand name
Humalog among others, is a
modified type of
medical insulin used to
treat type 1 and type 2 diabetes. It is delivered...
-
particularly at
nighttime (basal insulin). The
first insulin analog (insulin
Lispro rDNA) was
approved for
human therapy in 1996 and was
manufactured by Eli...
- A10AC04
Insulin lispro A10AC30
Combinations A10AD01
Insulin (human) A10AD02
Insulin (beef) A10AD03
Insulin (pork) A10AD04
Insulin lispro A10AD05 Insulin...
- company's
primary revenue drivers are the
diabetes drugs Humalog (insulin
lispro) (1996) and
Trulicity (dulaglutide) (2014).
Lilly was the
first company...
-
Nordisk produces recombinant biosynthetic human insulin 1996
Lilly Humalog "
lispro"
insulin analogue approved. 2000
Sanofi Aventis Lantus insulin "glargine"...
- fast-acting
Insulin aspart Insulin glulisine Insulin lispro short-acting
Regular insulin# long-acting
Insulin detemir#
Insulin glargine# (+lixisenatide)...
-
Adlyxin (Lixisenatide), for type 2
diabetes mellitus.
Admelog (insulin
lispro), for type 1 and type 2
diabetes mellitus.
Afrezza (Inhalable insulin),...
- fast-acting
Insulin aspart Insulin glulisine Insulin lispro short-acting
Regular insulin# long-acting
Insulin detemir#
Insulin glargine# (+lixisenatide)...
- Company, EGFR, GCSF, Fermentation, Orlistat,
Insulin Glargine,
Insulin Lispro, Peptides,
Insulin Aspart".
Archived from the
original on 7
August 2014...
- fast-acting
Insulin aspart Insulin glulisine Insulin lispro short-acting
Regular insulin# long-acting
Insulin detemir#
Insulin glargine# (+lixisenatide)...
